JoAnn Pinkerton, MD, breaks down the highlights of NAMS updated position statement
Only about one in five postmenopausal women received appropriate meds
Further decreases in nonvertebral fractures with longer treatment
32% more strokes seen with odanacatib; development halted
18-month NNT of 28 for spine fracture in low-risk women
Study author admits fraud to Neurology